Skip to main content

Table 2 Class size and profile of classified medication pattern in reports with psychiatric medications during pregnancy

From: Adverse event reports in patients taking psychiatric medication during pregnancy from spontaneous reports in Japan and the United States: an approach using latent class analysis

Class

1

2

3

4

5

6

7

8

9

10

11

Class sizea

23.3%

17.2%

15.2%

11.1%

11.0%

5.7%

4.5%

3.9%

3.6%

2.6%

2.0%

Number of reports

n=2417

n=1789

n=1582

n=1153

n=1143

n=590

n=463

n=404

n=373

n=272

n=203

Hypnotics and sedatives, antianxietics

 Alprazolam

0.8%

13.6%

9.9%

11.4%

0.0%

0.0%

0.0%

0.0%

5.1%

0.0%

2.5%

 Lorazepam

0.2%

9.0%

3.2%

11.0%

0.0%

0.0%

4.8%

0.0%

0.0%

5.9%

27.1%

 Zolpidem tartrate

0.7%

9.8%

1.6%

14.2%

0.0%

0.0%

0.0%

0.0%

0.5%

0.0%

15.8%

 Diazepam

0.5%

4.4%

1.4%

11.7%

0.0%

0.5%

1.3%

0.0%

0.0%

0.0%

2.5%

Antiepileptics

 Lamotrigine

10.5%

7.2%

5.1%

0.1%

0.0%

45.1%

11.0%

0.0%

0.0%

0.7%

46.8%

 Levetiracetam

7.3%

1.7%

0.0%

0.0%

0.0%

30.3%

61.1%

0.0%

0.3%

2.2%

2.5%

 Clonazepam

1.6%

11.0%

6.1%

11.8%

0.0%

8.3%

11.4%

0.0%

1.1%

0.0%

48.8%

 Gabapentin

0.0%

18.4%

0.0%

0.0%

0.0%

1.4%

0.0%

0.0%

0.0%

100.0%

1.0%

 Topiramate

4.3%

9.8%

1.7%

0.0%

0.0%

0.0%

58.3%

0.0%

6.7%

0.0%

1.0%

 Divalproex sodium

11.1%

2.4%

1.3%

1.6%

0.0%

0.5%

3.9%

0.0%

0.3%

0.0%

2.0%

 Carbamazepine

2.5%

1.2%

0.0%

5.5%

0.0%

30.5%

7.1%

0.0%

0.0%

0.4%

1.5%

 Valproate sodium

3.8%

0.0%

0.0%

6.7%

0.0%

23.2%

2.8%

0.0%

0.0%

0.4%

0.0%

 Vigabatrin

4.9%

0.1%

0.0%

0.0%

0.0%

0.0%

19.4%

0.0%

0.0%

0.0%

0.0%

Antidepressant

 Paroxetine hydrochloride

0.0%

4.9%

8.2%

18.9%

100.0%

0.7%

0.0%

0.0%

4.6%

0.0%

0.0%

 Sertraline hydrochloride

9.9%

9.9%

14.6%

4.0%

0.0%

0.2%

1.5%

0.0%

99.7%

0.4%

21.2%

 Duloxetine hydrochloride

12.9%

9.1%

11.6%

0.0%

0.0%

0.0%

0.4%

0.0%

0.0%

0.0%

19.2%

 Fluoxetine hydrochloride

0.0%

14.3%

12.4%

2.6%

0.0%

0.0%

0.2%

0.0%

1.3%

0.0%

1.0%

 Escitalopram oxalate

3.8%

9.4%

8.5%

1.3%

0.0%

0.0%

0.4%

0.0%

13.7%

0.0%

6.4%

 Venlafaxine hydrochloride

1.3%

11.9%

4.0%

0.0%

0.0%

0.0%

1.3%

0.0%

1.6%

0.0%

8.4%

 Bupropion hydrochloride

0.0%

9.2%

4.2%

0.0%

0.0%

0.0%

0.0%

0.0%

2.4%

0.4%

13.3%

 Trazodone hydrochloride

0.0%

9.7%

2.7%

1.6%

0.0%

0.0%

0.0%

0.0%

0.0%

3.7%

9.4%

Antipsychotic agent

 Aripiprazole

0.0%

3.6%

23.6%

1.1%

0.0%

2.2%

0.0%

100.0%

0.0%

0.0%

96.1%

 Risperidone

2.9%

1.0%

5.1%

10.7%

0.0%

0.0%

1.1%

0.0%

0.0%

0.7%

24.6%

 Olanzapine

5.1%

1.5%

5.2%

4.0%

0.0%

0.0%

0.0%

0.0%

0.3%

0.0%

4.4%

 Quetiapine fumarate

0.9%

3.8%

4.0%

7.4%

0.0%

0.0%

0.0%

0.0%

0.5%

0.0%

22.7%

Other drugs

 Vitamins

0.0%

25.3%

5.8%

0.0%

0.0%

1.7%

15.8%

0.0%

45.6%

0.0%

7.4%

 Folic acid

0.0%

9.7%

0.0%

1.0%

0.0%

26.6%

13.2%

0.0%

5.1%

0.4%

3.0%

 Paracetamol

0.0%

17.6%

0.3%

3.3%

0.0%

1.9%

0.9%

0.0%

13.4%

0.0%

0.5%

 Oxybate sodium

0.0%

19.4%

2.5%

0.1%

0.0%

0.0%

0.0%

0.0%

0.8%

0.0%

1.0%

 Ibuprofen

0.0%

14.5%

0.3%

1.0%

0.0%

0.0%

0.2%

0.0%

10.2%

0.4%

0.0%

 Colecalciferol

0.0%

14.6%

0.1%

0.0%

0.0%

0.0%

3.2%

0.0%

5.1%

0.0%

1.0%

 Ondansetron hydrochloride

0.0%

11.7%

0.0%

0.1%

0.0%

0.0%

1.1%

0.0%

9.9%

0.4%

13.3%

 Levothyroxine sodium

0.0%

9.4%

0.6%

1.8%

0.0%

0.0%

2.6%

0.0%

4.0%

0.0%

5.4%

 Prednisone

0.0%

10.6%

0.0%

1.4%

0.0%

0.0%

2.8%

0.0%

3.2%

0.4%

0.0%

 Acetaminophen/hydrocodone bitartrate

0.0%

11.7%

0.0%

1.1%

0.0%

0.0%

0.2%

0.0%

1.1%

0.4%

0.0%

Number of exposed drugs

 1

98.8%

0.0%

0.2%

0.0%

88.3%

0.0%

0.0%

100.0%

0.0%

12.5%

0.0%

 2

1.2%

0.0%

51.8%

0.2%

7.4%

60.2%

14.0%

0.0%

5.1%

27.2%

0.0%

 3

0.0%

0.0%

34.8%

8.7%

4.3%

28.3%

27.4%

0.0%

8.3%

27.2%

0.0%

 4≤

0.0%

100.0%

13.2%

91.2%

0.0%

11.5%

58.5%

0.0%

86.6%

33.1%

100.0%

  1. aThe percentage of class size was calculated using total number of reports including JADER and FAERS-US
  2. The percentage of each medication was calculated using number of reports (small n) for each class as denominator